CTNS-RD-04 Gene Therapy Lowers Cystine Levels Safely: JAMA
CTNS-RD-04, an ex vivo gene therapy for cystinosis, showed reduced white-cell cystine levels and an acceptable safety profile in a small phase 1-2 clinical trial, providing early evidence of its…